Search

Sweet deal for Tate & Lyle as they acquire Chinese dietary fibres firm for $237m

Tate & Lyle has snapped up a prebiotic dietary fibre company from China-listed ChemPartner for $237m today.



Shares in the FTSE 250 food and drink ingredients firm jumped 2.6 per cent after it announced it would acquire Quantum Hi-Tech Biological in a $237m deal.


The sale is not set to be voted on by ChemPartner shareholders, Tate & Lyle said.

Bosses said the deal was aligned with its goal of becoming a growth-focused food and beverage solutions business and will allow it to add to its footprint in China and Asia.


Quantum posted revenues of $46m and earnings before interest, taxes, depreciation, and amortization (EBITDA) of $14m for the 11 months to 30th November.





Tags:

6 views0 comments

Related Posts

See All
logo.jpg

ADR Investors

Asset | Direction | Range

Start your investment journey today

Open an Account

78% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

Info

+44 (0) 7827 859 212

info@adrinvestors.com

Follow

  • Twitter
  • Instagram
  • Facebook
  • LinkedIn
  • trustpilot

Copyright © adrinvestors.com | an eToro partner.

​

eToro (Europe) Ltd., a Financial Services Company authorised and regulated by the Cyprus Securities Exchange Commission (CySEC) under the license # 109/10. eToro (UK) Ltd, a Financial Services Company authorised and regulated by the Financial Conduct Authority (FCA) under the license FRN 583263. eToro AUS Capital Pty Ltd. is authorised by the Australian Securities and Investments Commission (ASIC) to provide financial services under Australian Financial Services License 491139

 

Past performance is not an indication of future results.


General Risk Disclosure | Terms & Conditions

​

You should seek advice from an independent and suitably licensed financial advisor and ensure that you have the risk appetite, relevant experience and knowledge before you decide to trade. Under no circumstances shall ADR Investors or eToro have any liability to any person or entity for (a) any loss or damage in whole or part caused by, resulting from, or relating to any transactions related to CFDs or (b) any direct, indirect, special, consequential or incidental damages whatsoever.

​

Trading with ADR Investors via eToro by following and/or copying or replicating the trades of other traders involves a high level of risk, even when following and/or copying or replicating the top-performing traders. Such risks includes the risk that you may be following/copying the trading decisions of possibly inexperienced/unprofessional traders, or traders whose ultimate purpose or intention, or financial status may differ from yours. Past performance of an eToro Community Member is not a reliable indicator of their future performance. Content on eToro’s social trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of eToro – Your Social Investment Network.